vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Sila Realty Trust, Inc. (SILA). Click either name above to swap in a different company.
Sila Realty Trust, Inc. is the larger business by last-quarter revenue ($50.1M vs $31.1M, roughly 1.6× LIFECORE BIOMEDICAL, INC. \DE\). Sila Realty Trust, Inc. runs the higher net margin — 10.0% vs -32.1%, a 42.1% gap on every dollar of revenue. On growth, Sila Realty Trust, Inc. posted the faster year-over-year revenue change (7.6% vs -4.5%). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -0.6%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Sila Realty Trust, Inc. is a U.S.-based real estate investment trust that owns, operates, and acquires high-quality income-generating commercial properties. Its core portfolio covers industrial logistics facilities, office assets and mixed-use properties, serving tenants across logistics, corporate and retail segments to deliver stable long-term returns.
LFCR vs SILA — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $50.1M |
| Net Profit | $-10.0M | $5.0M |
| Gross Margin | 25.0% | 88.9% |
| Operating Margin | -9.9% | — |
| Net Margin | -32.1% | 10.0% |
| Revenue YoY | -4.5% | 7.6% |
| Net Profit YoY | -52.0% | -54.9% |
| EPS (diluted) | $-0.29 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $50.1M | ||
| Q3 25 | $31.1M | $49.8M | ||
| Q2 25 | — | $48.7M | ||
| Q1 25 | $35.2M | $48.3M | ||
| Q4 24 | $32.6M | $46.5M | ||
| Q3 24 | $24.7M | $46.1M | ||
| Q2 24 | — | $43.6M | ||
| Q1 24 | $35.7M | $50.6M |
| Q4 25 | — | $5.0M | ||
| Q3 25 | $-10.0M | $11.6M | ||
| Q2 25 | — | $8.6M | ||
| Q1 25 | $-14.8M | $7.9M | ||
| Q4 24 | $-6.6M | $11.1M | ||
| Q3 24 | $-16.2M | $11.9M | ||
| Q2 24 | — | $4.6M | ||
| Q1 24 | $15.6M | $15.0M |
| Q4 25 | — | 88.9% | ||
| Q3 25 | 25.0% | 88.1% | ||
| Q2 25 | — | 87.7% | ||
| Q1 25 | 28.0% | 86.9% | ||
| Q4 24 | 34.0% | 87.3% | ||
| Q3 24 | 21.8% | 87.4% | ||
| Q2 24 | — | 86.6% | ||
| Q1 24 | 33.3% | 89.0% |
| Q4 25 | — | — | ||
| Q3 25 | -9.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -25.7% | — | ||
| Q4 24 | -6.0% | — | ||
| Q3 24 | -46.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.5% | — |
| Q4 25 | — | 10.0% | ||
| Q3 25 | -32.1% | 23.3% | ||
| Q2 25 | — | 17.6% | ||
| Q1 25 | -42.0% | 16.4% | ||
| Q4 24 | -20.2% | 23.9% | ||
| Q3 24 | -65.7% | 25.9% | ||
| Q2 24 | — | 10.6% | ||
| Q1 24 | 43.8% | 29.6% |
| Q4 25 | — | $0.10 | ||
| Q3 25 | $-0.29 | $0.21 | ||
| Q2 25 | — | $0.15 | ||
| Q1 25 | $-0.47 | $0.14 | ||
| Q4 24 | $-0.25 | $0.20 | ||
| Q3 24 | $-0.53 | $0.21 | ||
| Q2 24 | — | $0.08 | ||
| Q1 24 | $0.42 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $32.3M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $1.3B |
| Total Assets | $235.2M | $2.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $32.3M | ||
| Q3 25 | $18.9M | $27.7M | ||
| Q2 25 | — | $24.8M | ||
| Q1 25 | $5.4M | $30.5M | ||
| Q4 24 | $9.5M | $39.8M | ||
| Q3 24 | — | $28.6M | ||
| Q2 24 | — | $87.0M | ||
| Q1 24 | — | $90.2M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $1.3B | ||
| Q3 25 | $-10.5M | $1.3B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | $2.2M | $1.4B | ||
| Q4 24 | $15.4M | $1.4B | ||
| Q3 24 | $-3.9M | $1.4B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | $17.7M | $1.5B |
| Q4 25 | — | $2.1B | ||
| Q3 25 | $235.2M | $2.1B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | $237.7M | $2.0B | ||
| Q4 24 | $255.4M | $2.0B | ||
| Q3 24 | $246.8M | $2.0B | ||
| Q2 24 | — | $2.1B | ||
| Q1 24 | $246.2M | $2.1B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $119.1M |
| Free Cash FlowOCF − Capex | $25.0K | — |
| FCF MarginFCF / Revenue | 0.1% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | 23.76× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $119.1M | ||
| Q3 25 | $1.8M | $30.0M | ||
| Q2 25 | — | $31.9M | ||
| Q1 25 | $1.2M | $24.1M | ||
| Q4 24 | $-6.1M | $132.8M | ||
| Q3 24 | $-613.0K | $29.1M | ||
| Q2 24 | — | $31.6M | ||
| Q1 24 | $-1.4M | $36.6M |
| Q4 25 | — | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-4.3M | — | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-4.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-7.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -12.1% | — | ||
| Q4 24 | -26.3% | — | ||
| Q3 24 | -16.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -21.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 13.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 17.8% | — |
| Q4 25 | — | 23.76× | ||
| Q3 25 | — | 2.59× | ||
| Q2 25 | — | 3.71× | ||
| Q1 25 | — | 3.06× | ||
| Q4 24 | — | 11.95× | ||
| Q3 24 | — | 2.43× | ||
| Q2 24 | — | 6.84× | ||
| Q1 24 | -0.09× | 2.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
SILA
Segment breakdown not available.
